A joint venture between The University of Melbourne and The Royal Melbourne Hospital.
This is why the University of Melbourne – a world leader in education, teaching and research excellence – and The Royal Melbourne Hospital – an internationally renowned institution providing outstanding care, research and learning – partnered to create the Peter Doherty Institute for Infection and Immunity (Doherty Institute); a centre of excellence where leading scientists and clinicians collaborate to improve human health globally.
Located in the heart of Melbourne’s Biomedical Precinct, the Doherty Institute is named in honour of Patron, Laureate Professor Peter Doherty, winner of the 1996 Nobel Prize in Physiology or Medicine for discovering how the immune system recognises virus-infected cells. Under the expert guidance of Director, University of Melbourne Professor Sharon Lewin, a leader in research and clinical management of HIV and infectious diseases, the Doherty Institute has more than 700 staff who work on infection and immunity through a broad spectrum of activities. This includes discovery research; diagnosis, surveillance and investigation of infectious disease outbreaks; and the development of ways to prevent, treat and eliminate infectious diseases.
To improve health globally through discovery research and the prevention, treatment and cure of infectious diseases.
The Doherty Institute has created a governance structure that supports integration and fosters collaboration, strong leadership and management, creating a unified organisation.
This Strategic Plan provides a roadmap for the development of the Doherty Institute from 2022 to 2027. The plan sets out the ambition and vision for the Institute supported by a series of strategies and associated tactics which, when pursued to completion, will be expected to deliver the desired institutional culture and outcomes over time.
